PDCD1 and melanoma: Additionally, in the mice models, the neutralization of TNFα improved the effectiveness of cancer immunotherapy, ameliorated immunotherapy-induced colitis, and overcame resistance to anti-PD-1 blockade in mouse melanoma [83,84,85].